HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshitaka Sekido Selected Research

1-methyl-1-piperidinomethane sulfonate

11/2017Hyaluronic acid enhances cell migration and invasion via the YAP1/TAZ-RHAMM axis in malignant pleural mesothelioma.
12/2009Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
11/2008YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshitaka Sekido Research Topics

Disease

75Neoplasms (Cancer)
02/2024 - 05/2002
44Malignant Mesothelioma
11/2022 - 09/2003
27Lung Neoplasms (Lung Cancer)
06/2018 - 05/2002
15Mesothelioma
01/2023 - 09/2003
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 09/2003
8Adenocarcinoma of Lung
07/2019 - 01/2009
7Carcinogenesis
02/2024 - 09/2005
7Neurofibromatosis 2 (Neurofibromatosis Type II)
03/2018 - 03/2008
4Adenocarcinoma
12/2015 - 12/2005
3Glioma (Gliomas)
07/2013 - 06/2008
2Pancreatic Neoplasms (Pancreatic Cancer)
09/2021 - 04/2018
2Fibrosis (Cirrhosis)
04/2020 - 03/2012
2Hepatocellular Carcinoma (Hepatoma)
03/2019 - 11/2007
2Meningioma (Meningiomas)
03/2018 - 07/2015
2Neoplasm Metastasis (Metastasis)
01/2017 - 04/2011
2Infections
02/2014 - 05/2012
2Glioblastoma (Glioblastoma Multiforme)
07/2013 - 08/2012
2Stomach Neoplasms (Stomach Cancer)
08/2011 - 08/2007
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2010 - 11/2005
2Chromosomal Instability (Chromosome Stability)
07/2010 - 04/2008
1Mitochondrial Diseases (Mitochondrial Disease)
02/2024
1Ataxia Telangiectasia (Louis Bar Syndrome)
10/2023
1Pleural Effusion (Pleural Effusions)
01/2023
1Hematologic Neoplasms (Hematological Malignancy)
09/2021
1Granuloma
04/2020
1Peritoneal Fibrosis
04/2020

Drug/Important Bio-Agent (IBA)

24AsbestosIBA
01/2023 - 05/2006
13Proteins (Proteins, Gene)FDA Link
10/2023 - 03/2008
12ErbB Receptors (EGF Receptor)IBA
04/2016 - 12/2005
11Neurofibromin 2 (Merlin)IBA
01/2023 - 11/2008
10Phosphotransferases (Kinase)IBA
10/2023 - 12/2005
8Tyrosine Kinase InhibitorsIBA
04/2016 - 12/2009
7Gefitinib (Iressa)FDA Link
04/2013 - 12/2005
6Messenger RNA (mRNA)IBA
01/2023 - 07/2002
5Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2015 - 08/2006
4MicroRNAs (MicroRNA)IBA
03/2018 - 11/2005
4ChromatinIBA
07/2013 - 08/2007
4Cyclin-Dependent Kinase Inhibitor p16IBA
07/2013 - 07/2002
4Tumor Suppressor Protein p14ARF (p14ARF)IBA
01/2010 - 07/2002
4Histones (Histone)IBA
06/2008 - 08/2007
3IronIBA
02/2024 - 01/2012
3CarcinogensIBA
01/2019 - 01/2003
31-methyl-1-piperidinomethane sulfonateIBA
11/2017 - 11/2008
3Transcription Factors (Transcription Factor)IBA
03/2012 - 03/2008
3DNA (Deoxyribonucleic Acid)IBA
06/2008 - 07/2002
3beta CateninIBA
07/2006 - 09/2003
2Glutathione (Reduced Glutathione)IBA
02/2024 - 01/2017
2Ringer's LactateIBA
02/2024 - 01/2021
2Cell Adhesion Molecule-1IBA
01/2022 - 07/2019
2AntibodiesIBA
01/2022 - 01/2015
2Monoclonal AntibodiesIBA
01/2022 - 04/2018
2AntigensIBA
09/2021 - 06/2008
2Small Interfering RNA (siRNA)IBA
06/2018 - 04/2017
2Connective Tissue Growth FactorIBA
04/2018 - 09/2012
2Polycomb Repressive Complex 2IBA
01/2018 - 07/2013
2Protein Isoforms (Isoforms)IBA
01/2017 - 07/2010
2Cisplatin (Platino)FDA LinkGeneric
10/2016 - 06/2008
2Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
01/2013 - 05/2012
2Calcibiotic Root Canal SealerIBA
04/2011 - 11/2010
2JBIR-23IBA
01/2011 - 01/2009
2Cadherins (E-Cadherin)IBA
10/2010 - 03/2008
2CytokinesIBA
12/2009 - 08/2002
2DecitabineFDA Link
06/2008 - 09/2002
2Lysine (L-Lysine)FDA Link
06/2008 - 04/2008
2MethyltransferasesIBA
04/2008 - 07/2002
2Irinotecan (Camptosar)FDA LinkGeneric
01/2005 - 05/2002
1Biomarkers (Surrogate Marker)IBA
01/2023
1pro-brain natriuretic peptide (1-76)IBA
01/2023
15-nitro-2-(3-phenylpropylamino)benzoic acidIBA
01/2023
1Polysaccharides (Glycans)IBA
01/2022
1InterleukinsIBA
09/2021
1Oxytocin (Pitocin)FDA LinkGeneric
09/2021
1Hormones (Hormone)IBA
09/2021
1MesothelinIBA
09/2021
1CC ChemokinesIBA
09/2021
1Neurotransmitter Agents (Neurotransmitter)IBA
09/2021
1cligosibanIBA
09/2021
1LigandsIBA
09/2021
1Chimeric Antigen ReceptorsIBA
09/2021
1Oxytocin Receptors (Oxytocin Receptor)IBA
09/2021
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
09/2021
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2021
1CitrullineIBA
01/2021
1Mechanistic Target of Rapamycin Complex 1IBA
01/2021
1Plasma GasesIBA
01/2021
1anthophylliteIBA
04/2020
1TalcFDA Link
04/2020
1Serpentine Asbestos (Chrysotile)IBA
04/2020
1tremolite (bredigite)IBA
04/2020
1Immunoglobulins (Immunoglobulin)IBA
07/2019
1Fetal Proteins (Fetoprotein)IBA
03/2019
1acarboxyprothrombin (PIVKA)IBA
03/2019
1Vitamin KFDA Link
03/2019

Therapy/Procedure

17Therapeutics
02/2024 - 01/2003
3Drug Therapy (Chemotherapy)
01/2017 - 05/2002
2Immunotherapy
12/2018 - 06/2008
1Oral Administration
09/2021
1Intraperitoneal Injections
04/2020
1Proton Therapy
03/2019
1Aftercare (After-Treatment)
03/2019